Investigator(s): The Lundquist Institute

The Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) will honor one of the Palos Verdes Estate’s leading businessmen and philanthropists, Ralph Scriba, with its Award for Community Service, and one of its most distinguished researchers, Kouichi R. “Corky” Tanaka, MD, of Rancho Palos Verdes, with its Award for Inspirational Leadership at the institute’s Translating Science and Transforming Lives Gala Dec. 5 at the Beverly Wilshire Hotel in Beverly Hills.

Investigator(s): The Lundquist Institute

A new study found that men who live the longest are those who have medium testosterone levels. High or low testosterone levels are linked to reduced mortality. Testosterone is a key male sex hormone involved in maintaining sex drive, sperm production and bone health. Physicians have long known that low testosterone levels can signal health problems, but the new study found men may not fare better when levels of the hormone rise too high.

Investigator(s): The Lundquist Institute

American Lung Association report reveals that women are at greater risk than men

W omen are 37 percent more likely to have chronic obstructive pulmonary disease (COPD) than men and now account for more than half of all deaths attributed to COPD in our nation. The American Lung Association’s latest health disparity report, “Taking Her Breath Away: The Rise of COPD in Women,” examines the nation’s third leading cause of death and its increased prevalence among women throughout the U.S.

Investigator(s): The Lundquist Institute

At one point in our lives we have all heard genes play a large part in our destiny. Yet we have seen or heard of identical twins who have gone to live extremely different lives. It is quite evident that our genes aren’t everything. Indeed the unprecedentedly increasing rates of obesity and diabetes in Australia clearly demonstrate that our choices in diet and sedentary lifestyles are impacting our health.

Investigator(s): The Lundquist Institute

Medical Daily

By Peter Sergo | Oct 24, 2013 07:23 PM EDT

In 1945, Alexander Fleming, the discoverer of penicillin, already noticed bacteria’s ominous ability to acquire resistance to the antibiotic that saved so many lives. At the time, he even warned that overuse of penicillin would lead to more people dying from infections that are impervious to the revolutionary treatment.

Investigator(s): The Lundquist Institute

$6.4 Million Grant Funds Study Glaucoma in African-Americans

A study led by Robert N. Weinreb, chairman and Distinguished Professor of Ophthalmology at the University of California, San Diego School of Medicine, has received a $6.4 million, 5-year grant from the National Eye Institute, part of the National Institutes of Health, to elucidate the genetics of glaucoma in persons of African descent.

Investigator(s): The Lundquist Institute

By Sandy Mazza, Daily Breeze

 

Posted: 10/12/13, 2:55 PM PDT | Updated: on 10/14/2013

 

 

Lisa Lancaster drove an old car and wore modest clothes to the Inglewood office where she spent two decades administering nutritional and health aid to low-income women and children.

Investigator(s): The Lundquist Institute

A team of researchers will use state-of-the-art brain imaging to unlock the secrets of a genetic disease, mucopolysaccharidosis (MPS), in a landmark study the team hopes will lead to new treatments for this devastating disease.

Investigator(s): The Lundquist Institute

The Scientist

By Tracy Vence | September 25, 2013

Employing a treatment framework in which clinicians administer different drugs in strategic succession could both treat bacterial infections and select against the development of resistance, Technical University of Denmark’s Lejla Imamovic and Morten Sommer argue today (September 25) in Science Translational Medicine. This new framework, which the researchers call collateral sensitivity cycling, could also help curb unnecessary antibiotic use, which is known to contribute to the emergence of drug-resistant superbugs.